Cannabinoids, Insomnia, and Other Sleep Disorders DOI
Isobel Lavender, Iain S. McGregor, Anastasia Suraev

et al.

CHEST Journal, Journal Year: 2022, Volume and Issue: 162(2), P. 452 - 465

Published: May 7, 2022

Language: Английский

The effect of mindfulness meditation on sleep quality: a systematic review and meta‐analysis of randomized controlled trials DOI
Heather L. Rusch, Michael Del Rosario,

Lisa M. Levison

et al.

Annals of the New York Academy of Sciences, Journal Year: 2018, Volume and Issue: 1445(1), P. 5 - 16

Published: Dec. 21, 2018

Abstract There is a growing interest in the effectiveness of mindfulness meditation for sleep disturbed populations. Our study sought to evaluate effect interventions on quality. To assess relative efficacy, comparator groups were restricted specific active controls (such as evidenced‐based treatments) and nonspecific time/attention‐matched control placebo effects), which analyzed separately. From 3303 total records, 18 trials with 1654 participants included. We determined strength evidence using four domains (risk bias, directness outcome measures, consistency results, precision results). At posttreatment follow‐up, there was low that had no quality compared (ES 0.03 (95% CI –0.43 0.49)) –0.14 –0.62 0.34)), respectively. Additionally, moderate significantly improved at postintervention 0.33 0.17–0.48)) follow‐up 0.54 0.24–0.84)). These preliminary findings suggest may be effective treating some aspects disturbance. Further research warranted.

Language: Английский

Citations

371

The European Academy for Cognitive Behavioural Therapy for Insomnia: An initiative of the European Insomnia Network to promote implementation and dissemination of treatment DOI Creative Commons
Chiara Baglioni, Ellemarije Altena, Bjørn Bjorvatn

et al.

Journal of Sleep Research, Journal Year: 2019, Volume and Issue: 29(2)

Published: Dec. 19, 2019

Abstract Insomnia, the most prevalent sleep disorder worldwide, confers marked risks for both physical and mental health. Furthermore, insomnia is associated with considerable direct indirect healthcare costs. Recent guidelines in US Europe unequivocally conclude that cognitive behavioural therapy (CBT‐I) should be first‐line treatment disorder. Current approaches are stark contrast to these clear recommendations, not least across Europe, where, if any at all delivered, hypnotic medication still dominant therapeutic modality. To address this situation, a Task Force of European Sleep Research Society Insomnia Network met May 2018. The proposed establishing CBT‐I Academy would enable Europe‐wide system standardized training centre accreditation. This article summarizes deliberations concerning definition ingredients CBT‐I, preconditions health professionals teach way which taught, who taught whom administered. diverse aspects care delivery were discussed incorporated into stepped‐care model insomnia.

Language: Английский

Citations

204

Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment DOI Open Access
Jack D. Edinger, J. Todd Arnedt, Suzanne M. Bertisch

et al.

Journal of Clinical Sleep Medicine, Journal Year: 2020, Volume and Issue: 17(2), P. 263 - 298

Published: Nov. 9, 2020

The purpose of this systematic review is to provide supporting evidence for a clinical practice guideline on the use behavioral and psychological treatments chronic insomnia disorder in adult populations. American Academy Sleep Medicine commissioned task force 9 experts sleep medicine psychology. A was conducted identify randomized controlled trials that addressed interventions treatment adults. Statistical analyses were performed determine if produced clinically significant improvements range critical important outcomes. Finally, Grading Recommendations Assessment, Development, Evaluation process used evaluate making specific recommendations. literature search identified 1,244 studies; 124 studies met inclusion criteria, 89 provided data suitable statistical analyses. Evidence following presented review: cognitive-behavioral therapy insomnia, brief therapies stimulus control, restriction therapy, relaxation training, hygiene, biofeedback, paradoxical intention, intensive retraining, mindfulness. This provides detailed summary along with quality evidence, balance benefits vs harms, patient values preferences, resource considerations.

Language: Английский

Citations

204

Comparative efficacy of onsite, digital, and other settings for cognitive behavioral therapy for insomnia: a systematic review and network meta-analysis DOI Creative Commons
Laura Simon, Lisa Steinmetz, Bernd Feige

et al.

Scientific Reports, Journal Year: 2023, Volume and Issue: 13(1)

Published: Feb. 2, 2023

Given the limited availability and accessibility of onsite cognitive behavioral therapy for insomnia (CBT-I), other CBT-I settings, such as internet-delivered (iCBT-I), have been proposed. The primary aim study was to compare efficacy available settings on severity. A systematic review frequentist network meta-analysis performed. PsycINFO, PsycARTICLES, MEDLINE, PubMed, CINAHL were searched randomized controlled trials (RCTs) investigating any in adults with disorder. literature search (3851 references) resulted 52 RCTs. For outcome severity, all examined except smartphone-delivered yielded significant effects when compared WL. Large standardized mean differences found individual (- 1.27;95%CI - 1.70, 0.84), group-delivered 1.00;95%CI 1.42. 0.59), telehealth 1.28;95%CI 2.06, 0.50), guided bibliotherapy 0.99;95%CI 1.67, 0.32). Both iCBT-I 0.71;95%CI 1.18, 0.24) unguided 0.78;95%CI 0.38) medium effect sizes. results underline that health care systems should intensify their efforts provide synchronously-delivered (individual onsite, group-delivered, telehealth), particularly CBT-I, given its solid evidence base. Medium large sizes indicate self-help may be a viable alternative is not available.

Language: Английский

Citations

60

Depression prevention via digital cognitive behavioral therapy for insomnia: a randomized controlled trial DOI Open Access
Philip Cheng, David A. Kalmbach,

Gabriel Tallent

et al.

SLEEP, Journal Year: 2019, Volume and Issue: 42(10)

Published: Sept. 17, 2019

Insomnia is a common precursor to depression; yet, the potential for insomnia treatment prevent depression has not been demonstrated. Cognitive behavioral therapy (CBT-I) effectively reduces concurrent symptoms of and can be delivered digitally (dCBT-I); however, it remains unclear whether treating leads sustained reduction prevention depression. This randomized controlled trial examined efficacy dCBT-I in reducing preventing over 1-year follow-up period.Patients with Diagnostic Statistical Manual Mental Disorders, Fifth Edition (DSM-5) disorder were randomly assigned receive or an attentional control. The sample included 358 patients condition 300 online sleep education condition. primary outcome measure was relative rate ratios at follow-up. responses also tested as predictors incident follow-up.At follow-up, severity continued significantly lower In addition, number individuals who reported no 51% higher those minimal baseline, moderate-to-severe reduced by half control condition.dCBT-I showed robust effects intervention that prevents Future research should examine dose-response requirements further characterize mechanisms action prevention.Sleep Prevent Evolving Affective Disorders; NCT02988375.

Language: Английский

Citations

130

A randomized controlled trial of digital cognitive behavioral therapy for insomnia in pregnant women DOI
David A. Kalmbach, Philip Cheng, Louise M. O’Brien

et al.

Sleep Medicine, Journal Year: 2020, Volume and Issue: 72, P. 82 - 92

Published: March 21, 2020

Language: Английский

Citations

113

Evaluation and management of insomnia in women with breast cancer DOI
Agnes H. Kwak, Jamie M. Jacobs, Dana Haggett

et al.

Breast Cancer Research and Treatment, Journal Year: 2020, Volume and Issue: 181(2), P. 269 - 277

Published: April 20, 2020

Language: Английский

Citations

84

Effects of Lactobacillus plantarum PS128 on Depressive Symptoms and Sleep Quality in Self-Reported Insomniacs: A Randomized, Double-Blind, Placebo-Controlled Pilot Trial DOI Open Access

Yu-Ting Ho,

Ying-Chieh Tsai, Terry B. J. Kuo

et al.

Nutrients, Journal Year: 2021, Volume and Issue: 13(8), P. 2820 - 2820

Published: Aug. 17, 2021

Recent animal studies have supported that Lactobacillus plantarum PS128 (PS128) can reduce the severity of anxiety and depression. However, previous did not focus on sleep quality mood humans. This study determines whether reduces depressive symptoms, regulates autonomic nervous system function, improves quality. Forty participants between 20 40 years age with self-reported insomnia were randomly assigned to two groups, a group placebo group, in double-blind trial. Participants took capsules either or after dinner for 30 days. Study measures included subjective questionnaires, miniature-polysomnography recordings at baseline 15th 30th days taking capsules. Overall, all outcomes comparable groups within 30-day period, yet some differences still found. Compared control showed significant decreases Beck Depression Inventory-II scores, fatigue levels, brainwave activity, awakenings during deep stage. Their improved symptoms related changes brain waves maintenance. These findings suggest daily administration may lead decrease level, cortical excitation, an improvement Daily consumption as dietary supplement improve insomniacs, although further investigation is warranted.

Language: Английский

Citations

72

Effect of Telephone Cognitive Behavioral Therapy for Insomnia in Older Adults With Osteoarthritis Pain DOI Open Access
Susan M. McCurry, Weiwei Zhu,

Michael Von Korff

et al.

JAMA Internal Medicine, Journal Year: 2021, Volume and Issue: 181(4), P. 530 - 530

Published: Feb. 22, 2021

Importance

Scalable delivery models of cognitive behavioral therapy for insomnia (CBT-I), an effective treatment, are needed widespread implementation, particularly in rural and underserved populations lacking ready access to treatment.

Objective

To evaluate the effectiveness telephone CBT-I vs education-only control (EOC) older adults with moderate severe osteoarthritis pain.

Design, Setting, Participants

This is a randomized clinical trial 327 participants 60 years who were recruited statewide through Kaiser Permanente Washington from September 2016 December 2018. Participants double screened 3 weeks apart (OA) pain symptoms. Blinded assessments conducted at baseline, after 2 months posttreatment, 12-month follow-up.

Interventions

Six 20- 30-minute sessions provided over 8 weeks. submitted daily diaries received group-specific educational materials. The instruction included sleep restriction, stimulus control, hygiene, restructuring, homework. EOC group information about OA.

Main Outcomes Measures

primary outcome was score on Insomnia Severity Index (ISI) posttreatment Secondary outcomes (score Brief Pain Inventory-short form), depression 8-item Patient Health Questionnaire), fatigue Flinders Fatigue Scale).

Results

Of participants, mean (SD) age 70.2 (6.8) years, 244 (74.6%) women. In 282 follow-up ISI data, total 2-month scores decreased 8.1 points 4.8 group, adjusted between-group difference −3.5 (95% CI, −4.4 −2.6 points;P < .001). Results sustained (adjusted difference, −3.0 points; 95% −4.1 −2.0 At follow-up, 67 119 (56.3%) receiving remained remission (ISI score, ≤7) compared 33 128 (25.8%) EOC. also significantly reduced (mean −3.1 −0.9 = <.001) −1.8 −0.6 .003). Posttreatment significant differences observed pain, but these not

Conclusions Relevance

this trial, improving sleep, fatigue, and, lesser degree, among comorbid OA large health plan. support provision as accessible, individualized, effective, scalable

Trial Registration

Clinical Trials.gov Identifier:NCT02946957

Language: Английский

Citations

67

We know CBT-I works, now what? DOI Open Access
Alexandria Muench, Iván Vargas, Michael A. Grandner

et al.

Faculty Reviews, Journal Year: 2022, Volume and Issue: 11

Published: Feb. 1, 2022

Cognitive behavioral therapy for insomnia (CBT-I) has been shown to be efficacious and now is considered the first-line treatment both uncomplicated that occurs comorbidly with other chronic disorders (comorbid insomnia). The purposes of this review are provide a comprehensive summary efficacy data (for example, overall by clinical demographic considerations CBT-I formulation) discuss future what next steps should taken in terms research, dissemination, implementation, practice).

Language: Английский

Citations

55